Steatotic liver disease is the overarching term for conditions characterised by abnormal lipid
accumulation in the liver (liver or hepatic steatosis). Steatotic liver disease encompasses …

Liver disease prevalence, severity, outcomes and hepatic risk factors (for example,
unhealthy diet) are heavily affected by socioeconomic status and food insecurity. Metabolic …

Background & Aims Both metabolic dysfunction and alcohol consumption cause steatotic
liver disease (SLD). The distinction between metabolic dysfunction-associated SLD …

Background & Aims The epidemiology of adult primary liver cancer continues to evolve,
owing to the increasing prevalence of metabolic disease, rising alcohol consumption …

Opportunities and challenges following approval of resmetirom for MASH liver disease | Nature
Medicine Skip to main content Thank you for visiting nature.com. You are using a browser …

The liver, as a central metabolic organ, is systemically linked to metabolic–inflammatory
diseases. In the pathogenesis of the metabolic syndrome, inflammatory and metabolic …

Background: Metabolic dysfunction–associated steatohepatitis (MASH) is associated with
high health care costs. This US study investigated the economic burden of MASH …

Nonalcoholic fatty liver disease (NAFLD), or metabolic dysfunction-associated steatotic liver
disease (MASLD), is a liver condition that is linked to overweight, obesity, diabetes mellitus …

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most prevalent
chronic liver disease globally, and can lead to hepatocellular carcinoma (HCC), a leading …

Conclusions: Most guidelines recommend weight reduction through physical activity and
improving nutrition, as these have proven positive effects on health outcomes when …